BlinkLab news

Read BlinkLab's latest company news, research updates, partnerships, and media mentions.

BlinkLab Expands into Therapy Evaluation for Neurodevelopmental Conditions with Erasmus MC

BlinkLab has entered into an academic research agreement with Erasmus University Medical Center, a world-renowned medical research institution in The Netherlands.

•

May 19, 2026

In the media

View all

May 26, 2026

Healthcare innovation pours into the Yarra Valley

Read the article

May 18, 2026

Morgans names 2 small-cap ASX shares to buy

Read the article

May 18, 2026

ASX 200 Small-Cap Watch: Why Accent and BlinkLab Are Drawing Market Attention

Read the article

May 1, 2026

Brian Leedman, Non-Executive Chairman, outlines BlinkLab’s digital biomarker technology and clinical pathway

Read the article

BlinkLab news

BlinkLab Expands into Therapy Evaluation for Neurodevelopmental Conditions with Erasmus MC

BlinkLab has entered into an academic research agreement with Erasmus University Medical Center, a world-renowned medical research institution in The Netherlands.

May 19, 2026

BlinkLab Presents at Stocks in the Vines Investor Access Day

BlinkLab's Chairman, Mr Brian Leedman presented at the Stocks in the Vines – Investor Access Day in the Yarra Valley, Victoria.

May 14, 2026

BlinkLab Secures A$17.5M to Fund the Launch of Autism Diagnostic Aid and Expand ADHD Program

BlinkLab successfully completes an oversubscribed placement new shares to sophisticated and institutional investors; raising a total of A$17.5 million (before costs).

Apr 16, 2026

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab announced the commencement of its validation program supporting 510(k) submission, with the first child participant now enrolled and having completed initial testing using BlinkLab Dx1.

Mar 24, 2026

BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program

BlinkLab announces its involvement in a landmark national autism screening and capacity-building initiative launched by the Kingdom of Morocco.

Mar 23, 2026

Completion of Clinical Trial Network for Pivotal FDA Study with Addition of Tenth Clinical Site – University of Arkansas

BlinkLab announces the onboarding of University of Arkansas as the tenth and final clinical site for the Company’s upcoming pivotal U.S. regulatory trial for BlinkLab Dx 1.

Mar 16, 2026

Want to feature BlinkLab?

If you want to request an interview, need any assets or insights, feel free to reach out to BlinkLab's CEO, Henk-Jan Boele.

Send an email

BlinkLab news

BlinkLab Expands into Therapy Evaluation for Neurodevelopmental Conditions with Erasmus MC

In the media

Healthcare innovation pours into the Yarra Valley

Morgans names 2 small-cap ASX shares to buy

ASX 200 Small-Cap Watch: Why Accent and BlinkLab Are Drawing Market Attention

Brian Leedman, Non-Executive Chairman, outlines BlinkLab’s digital biomarker technology and clinical pathway

BlinkLab news

BlinkLab Expands into Therapy Evaluation for Neurodevelopmental Conditions with Erasmus MC

BlinkLab Presents at Stocks in the Vines Investor Access Day

BlinkLab Secures A$17.5M to Fund the Launch of Autism Diagnostic Aid and Expand ADHD Program

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program

Completion of Clinical Trial Network for Pivotal FDA Study with Addition of Tenth Clinical Site – University of Arkansas

Want to feature BlinkLab?

Help us improve diagnostic evaluations for autism

Awesome! You're now signed up.

BlinkLab news

BlinkLab Expands into Therapy Evaluation for Neurodevelopmental Conditions with Erasmus MC

In the media

Healthcare innovation pours into the Yarra Valley

Morgans names 2 small-cap ASX shares to buy

ASX 200 Small-Cap Watch: Why Accent and BlinkLab Are Drawing Market Attention

Brian Leedman, Non-Executive Chairman, outlines BlinkLab’s digital biomarker technology and clinical pathway

BlinkLab news

BlinkLab Expands into Therapy Evaluation for Neurodevelopmental Conditions with Erasmus MC

BlinkLab Presents at Stocks in the Vines Investor Access Day

BlinkLab Secures A$17.5M to Fund the Launch of Autism Diagnostic Aid and Expand ADHD Program

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program

Completion of Clinical Trial Network for Pivotal FDA Study with Addition of Tenth Clinical Site – University of Arkansas

Want to feature BlinkLab?

Help us improve diagnostic evaluations for autism

Subscribe to the newsletter

Awesome! You're now signed up.